The Role of Biomarkers in Monitoring Liver Disease ‎Progression: Insights into AFP, and P53‎ ‏

نوع المستند : المقالة الأصلية

المؤلفون

1 ‎ Natural Products Unit, Medicinal and Aromatic Department, Desert ‎Research Center, Cairo, Egypt‎

2 Agro-Industrialization Unit, Department of Plant Production, Desert ‎Research Center, Cairo, Egypt‎

3 Infectious Disease Unit, Animal and Poultry Health Department, ‎Animal and Poultry Production Division, Desert Research Center, ‎Cairo, Egypt‎

المستخلص

Non-alcoholic fatty liver disease (NAFLD) is a growing global health concern, often progressing to hepatocellular carcinoma (HCC), a leading cause of liver cancer. This research investigates the relationship between NAFLD and HCC in HepG2 cells and the roles of p53 and alpha-fetoprotein (AFP) in these processes. The study investigated that the inactivation of p53 (NAFLD = 22.5 ±2.02U/ml, HCC = 55 ±2.21U/ml) contributes to the progression of NAFLD to HCC, and that elevated AFP levels (NAFLD = 13 ±1.17ng/ml, HCC = ±1.2ng/ml) serve as both a biomarker and a contributor to liver carcinogenesis (p-value < 0.5). The findings highlight that the elevated values of AFP, but not of P53, may help in understanding the transformation in the context of NAFLD and liver cancer.

ملفات

شارك

إرسال الاستشهاد إلى

الإحصائيات